Infographics - Veterinary Vaccines Market

Global veterinary vaccines market is estimated to be valued at USD 9.70 Bn in 2024 and is expected to exhibit a CAGR of 7.6% during the forecast period (2024-2031). Veterinary vaccines are biological preparations administered to animals in order to stimulate the immune system and provide active immunity against a disease. Vaccination protects individual animals from infectious diseases and generates herd immunity which indirectly protects the whole community. The global veterinary vaccine market has shown rapid expansion over the past few decades driven by the increasing awareness about animal healthcare as pets have become an integral part of people's families. Government mandates in various countries have also encouraged vaccination of livestock and companion animals. Advancements in vaccination technologies and recombinant procedures have enabled manufacturers to develop efficacious vaccines against a wide range of zoonotic diseases.

Market Dynamics:

The global veterinary vaccine market is driven by factors such as rising pet adoption, growing animal healthcare expenditure, government initiatives for animal disease control, increase in the risk of zoonotic diseases, and intensification of livestock farming. However, high cost of vaccine production, stringent regulations and lack of necessary infrastructure and expertise in some regions constrain market growth. Advancements in delivery systems, therapeutic approaches, and epitope mapping offer opportunities in the veterinary vaccines market. Pharmaceutical companies are developing recombinant protein and antitoxins for effective vaccination against swine fever, bird flu, rabies, and bovine tuberculosis which are major threats to animals as well as public health. Introduction of single-dose formulations and integrated needle-free injectors aim to reduce vaccination costs and improve convenience.

Key Features of the Study:

This report provides an in-depth analysis of the global veterinary vaccines market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global veterinary vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Aratana Therapeutics Inc., Regeneus Ltd., Morphogenesis Inc., Karyopharm Therapeutics Inc., Zoetis Inc., Eli Lilly and Company, Merck & Co. Inc., Boehringer Ingelheim GmbH., Elanco Animal Health, Virbac, Hester Biosciences Limited, Ceva Sante Animale, Phibro Animal Health Corporation, Kemin Industries, Inc., Finlab, Vaxxinova , Vira Vaccine Shaya, and VETERQUIMICA SA.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global veterinary vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary vaccines market.

Market Segmentation

Technology:
- Inactivated Vaccines
- Toxoid Vaccines
- Live Attenuated Vaccines
- Subunit and DNA Vaccines
- Recombinant Vaccines
Animal Type:
- Companion
  - Equine
  - Canine
  - Feline
- Livestock
  - Bovine
  - Ovine
  - Porcine
  - Poultry
  - Others
Route of Administration:
- Subcutaneous Injection
- Intramuscular Injection
- Intranasal Administration
- Others
Distribution Channel
- Public
- Private
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Aratana Therapeutics Inc.
- Regeneus Ltd.
- Morphogenesis Inc.
- Karyopharm Therapeutics Inc.
- Zoetis Inc.
- Eli Lilly and Company
- Merck & Co. Inc.
- Boehringer Ingelheim GmbH.
- Elanco Animal Health
- Virbac
- Hester Biosciences Limited
- Ceva Sante Animale
- Phibro Animal Health Corporation
- Kemin Industries, Inc.
- Finlab
- Vaxxinova
- Vira Vaccine Shaya
- VETERQUIMICA SA

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Technology
  - Market Snapshot, By Animal Type
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- PEST Analysis
Global Veterinary Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the Market
Global Veterinary Vaccine Market, By Technology, 2019 – 2031, (US$ Billion)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Inactivated Vaccines
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Toxoid Vaccine
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Live Attenuated Vaccines
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Subunit and DNA Vaccines
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Recombinant Vaccines
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
Global Veterinary Vaccine Market, By Animal Type, 2019 – 2031, (US$ Billion)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Companion
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    - Equine
    - Canine
    - Feline
- Livestock
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    - Bovine
    - Ovine
    - Porcine
    - Poultry
    - Others
Global Veterinary Vaccine Market, By Route of Administration, 2019 – 2031, (US$ Billion)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Subcutaneous Injection
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Intramuscular Injection
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Intranasal Administration
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
Global Veterinary Vaccine Market, By Distribution Channel, 2019 – 2031, (US$ Billion)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Public
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Private
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
Global Veterinary Vaccine Market, By Region, 2019 – 2031, (US$ Billion)
- Introduction
  - Market Share Analysis, By Region, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, For Regions, 2019–2031
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (US$ Billion)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Aratana Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Regeneus Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Morphogenesis, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Karyopharm Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Zoetis, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount